ATE219668T1 - Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie - Google Patents
Verwendung von natrium 2-mercaptoethansulfonat in der chirurgieInfo
- Publication number
- ATE219668T1 ATE219668T1 AT97909364T AT97909364T ATE219668T1 AT E219668 T1 ATE219668 T1 AT E219668T1 AT 97909364 T AT97909364 T AT 97909364T AT 97909364 T AT97909364 T AT 97909364T AT E219668 T1 ATE219668 T1 AT E219668T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- tissues
- mercaptoethanesulfonate
- sodium
- surgery
- Prior art date
Links
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 title abstract 2
- 238000001356 surgical procedure Methods 0.000 title 1
- ZNEWHQLOPFWXOF-UHFFFAOYSA-M coenzyme M(1-) Chemical compound [O-]S(=O)(=O)CCS ZNEWHQLOPFWXOF-UHFFFAOYSA-M 0.000 abstract 1
- 238000002316 cosmetic surgery Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96MI002117A IT1284973B1 (it) | 1996-10-11 | 1996-10-11 | Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia |
| PCT/EP1997/005485 WO1998016213A1 (en) | 1996-10-11 | 1997-10-07 | Use of sodium 2-mercaptoethanesulfonate in surgery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219668T1 true ATE219668T1 (de) | 2002-07-15 |
Family
ID=11375023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97909364T ATE219668T1 (de) | 1996-10-11 | 1997-10-07 | Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6143797A (de) |
| EP (1) | EP0930878B1 (de) |
| JP (1) | JP4208967B2 (de) |
| AT (1) | ATE219668T1 (de) |
| AU (1) | AU4707797A (de) |
| DE (1) | DE69713611T2 (de) |
| ES (1) | ES2178760T3 (de) |
| IT (1) | IT1284973B1 (de) |
| WO (1) | WO1998016213A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030175A1 (it) * | 2003-02-04 | 2004-08-05 | Giorgio Conti | Uso del 2-mercaptoetansolfonato di sodio come agente antivirale |
| WO2006065301A2 (en) * | 2004-12-10 | 2006-06-22 | Alcon, Inc. | Compositions for treatment of ear infections |
| CA2930817A1 (en) | 2013-11-17 | 2015-05-21 | Rdd Pharma Ltd. | Methods for treating radiation induced gastrointestinal tract injury |
| WO2021013713A1 (en) | 2019-07-19 | 2021-01-28 | Auxin Surgery Sa | Mesna composition, kit comprising mesna and method for visualization of a mesna composition applied to tissues |
| EP4093355B1 (de) * | 2020-01-24 | 2025-09-24 | Spiral Therapeutics Inc. | Systeme zur behandlung von hörverlust |
| CN116390726A (zh) * | 2020-08-26 | 2023-07-04 | 希拉治疗公司 | 可吸入治疗剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244920A (en) * | 1985-04-15 | 1993-09-14 | Schering Spa | Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt |
| EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
| DE4233842A1 (de) * | 1992-10-08 | 1994-04-14 | Asta Medica Ag | Mesna Injektionslösungen |
| US5661188A (en) * | 1995-06-07 | 1997-08-26 | Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch | Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna) |
-
1996
- 1996-10-11 IT IT96MI002117A patent/IT1284973B1/it active IP Right Grant
-
1997
- 1997-10-07 DE DE69713611T patent/DE69713611T2/de not_active Expired - Lifetime
- 1997-10-07 WO PCT/EP1997/005485 patent/WO1998016213A1/en not_active Ceased
- 1997-10-07 US US09/284,195 patent/US6143797A/en not_active Expired - Lifetime
- 1997-10-07 ES ES97909364T patent/ES2178760T3/es not_active Expired - Lifetime
- 1997-10-07 AU AU47077/97A patent/AU4707797A/en not_active Abandoned
- 1997-10-07 JP JP51797998A patent/JP4208967B2/ja not_active Expired - Fee Related
- 1997-10-07 EP EP97909364A patent/EP0930878B1/de not_active Expired - Lifetime
- 1997-10-07 AT AT97909364T patent/ATE219668T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69713611T2 (de) | 2003-01-30 |
| ITMI962117A1 (it) | 1998-04-11 |
| US6143797A (en) | 2000-11-07 |
| JP2001508033A (ja) | 2001-06-19 |
| EP0930878A1 (de) | 1999-07-28 |
| AU4707797A (en) | 1998-05-11 |
| IT1284973B1 (it) | 1998-05-28 |
| DE69713611D1 (de) | 2002-08-01 |
| JP4208967B2 (ja) | 2009-01-14 |
| EP0930878B1 (de) | 2002-06-26 |
| ES2178760T3 (es) | 2003-01-01 |
| WO1998016213A1 (en) | 1998-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2083595T3 (es) | Derivados de indol que inhiben la biosintesis de leucotrienos. | |
| ATE317262T1 (de) | Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion | |
| DK1140969T3 (da) | Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| BR9911017A (pt) | Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas | |
| DE59611411D1 (de) | Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz | |
| NO970805L (no) | Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme | |
| PT920323E (pt) | Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica | |
| DE69839696D1 (de) | Anellierte dihydropyrane | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
| BR9913705A (pt) | Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin | |
| DE69713611D1 (de) | Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie | |
| ATE374618T1 (de) | Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen | |
| ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
| DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE223721T1 (de) | Edelfosin zur behandlung von hirntumoren | |
| BR0113147A (pt) | Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos | |
| PT1152757E (pt) | Inibidores de mmp no amolecimento do tecido conjuntivo | |
| DE602004009414D1 (de) | BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE | |
| DE69724944D1 (de) | Peptidverbindungen mit mmp- und tnf-hemmender wirkung | |
| NO890801D0 (no) | Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer. | |
| ATE278407T1 (de) | Verwendung von d-galaktose zur verhinderung von nekrosen | |
| DE69532959D1 (de) | D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung | |
| DE69626010D1 (de) | Verwendung von tropolon derivate zur hemmung des inositmono phosphatase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |